Skip to Content

Invited Reviews

  • Tang DG, Tian HS.  Anti-cancer effect of NSAID indomethacin.  Oncology 5:273-277, 1989.
      
  • Tang DG, Tian HS.  The anti-tumor and anti-metastatic effect of indomethacin:  Exploration of its mechanisms of action.  J. Pharmacol. Biochem. Agents 11:151-153, 1990.
      
  • Tang DG, Tian HS.  Anti-metastatic effect of prostacyclin (PGI2): Experimental and clinical evidence.  J. Toxicol. Pharmacol.  2:83-86, 1990.
      
  • Honn KV, Tang DG, Chen Y.  Platelets and cancer metastasis: More than an epiphenomenon.  Seminar Thromb. Hemost. 18:390-413, 1992.
      
  • Chen Y, Liu B, Tang DG, Honn KV.  Fatty acid modulation of tumor cell-platelet-vessel wall interaction.  Cancer Metastasis Rev. 11:389-410, 1992.
      
  • Honn KV, Tang DG.  Hemostasis and metastasis: An overview.  Cancer Metastasis Rev. 11:223-226, 1992.
      
  • Honn KV, Tang DG, Crissman JD.  Platelets and cancer metastasis: A causal relationship?  Cancer Metastasis Rev. 11:325-351, 1992.
     
  • Honn KV, Tang DG.  Adhesion molecules and cancer cell interaction with endothelium and subendothelial matrix.  Cancer Metastasis Rev. 11:353-375, 1992.
     
  • Honn KV, Tang DG.  Commentary: Invasion and metastasis: New approaches to an old problem-The Kohn and Liotta Article Reviewed.  Oncology 7:61-62, 1993.
     
  • Tang DG, Honn KV.  12-Lipoxygenase, 12(S)-HETE, and cancer metastasis.  Annals N.Y. Acad. Sci. 722:199-215, 1994.
     
  • Honn KV, Tang DG, Gao X, Butovich I, Liu B, Timar J, Hagmann W.  12-Lipoxygenase and 12(S)-HETE: Role in cancer metastasis.  Cancer Metastasis Rev. 13:365-396, 1994.
     
  • Schneider MR, Tang DG, Honn KV.  Prostacyclin and its analogues: Antimetastatic effects and mechanisms of action.  Cancer Metastasis Rev. 13:349-364, 1994.
      
  • Tang DG, Honn KV.  Adhesion molecules and tumor metastasis: An update.  Invasion Metastasis 14:109-222, 1995.
     
  • Tang DG, Honn KV.  Adhesion molecules and tumor cell - vasculature interactions: Modulation by bioactive lipid molecules.  Curr. Topics Microbiol. Immunol. 213 (pt 2):69-88, 1996.
     
  • Honn KV, Aref A, Chen YQ, Cher ML, Crissman JD, Forman JD, Gao X, Grignon D, Hussain M, Porter AT, Pontes JE, Powell I, Redman B, Sakr W, Severson R, Tang DG, Wood DP, Jr.  Prostate Cancer: Old Problems and New Approaches. Part I: Epidemiology, incidence and genetic alterations.  Pathol. Oncol. Res. 2:98-109, 1996.
     
  • Honn KV, Aref A, Chen YQ, Cher ML, Crissman JD, Forman JD, Gao X, Grignon D, Hussain M, Porter AT, Pontes JE, Powell I, Redman B, Sakr W, Severson R, Tang DG, Wood DP, Jr.  Prostate Cancer: Old Problems and New Approaches. Part II: Diagnostic and prognostic markers, pathology, and biological aspects.  Pathol. Oncol. Res. 2:191-211, 1996.
     
  • Tang DG, Porter AT. Apoptosis: A current molecular analysis. Pathol. Oncol. Res. 2:117-137, 1996.
     
  • Honn KV, Aref A, Chen YQ, Cher ML, Crissman JD, Forman JD, Gao X, Grignon D, Hussain M, Porter AT, Pontes JE, Powell I, Redman B, Sakr W, Severson R, Tang DG, Wood DP, Jr.  Prostate Cancer: Old Problems and New Approaches. Part III: Prevention and treatment.  Pathol. Oncol. Res. 2:276-292, 1997.
     
  • Tang DG, Porter AT.  Target to apoptosis: A hopeful weapon for prostate cancer.  Prostate 32:284-293, 1997.
     
  • Tang DG, La E, Kern J, Kehrer JP.  Fatty acid oxidation and signaling in apoptosis.  Biol. Chem. 383:425-442, 2002.
     
  • Tang DG, Conti C. Endothelial cell development, vasculogenesis, angiogenesis and tumor neovascularization: an update. Semin. Thromb. Hemostasis. 30:109-117, 2004.
     
  • Laffin B and Tang DG. An old player on a new playground: Bmi-1 as a regulator of prostate stem cells. Cell Stem Cell, 7: 639-40, 2010.
     
  • Li H and Tang DG. Prostate cancer stem cells and their potential roles in metastasis. J. Surg. Oncol.  103:558-562, 2011.
     

© 2014 The University of Texas MD Anderson Cancer Center